Kyung Nam Pharm Co Ltd (053950) — Capital Reinvestment Ratio
Kyung Nam Pharm Co Ltd (053950) has a Capital Reinvestment Ratio of 47.04x as of June 2026, meaning it reinvests 47% of its operating cash flow (₩81.44 Million) in capital expenditures (₩3.83 Billion). Check tangible net worth ratio of Kyung Nam Pharm Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kyung Nam Pharm Co Ltd Capital Reinvestment Ratio (2007–2024)
This chart tracks Kyung Nam Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Kyung Nam Pharm Co Ltd (053950) cash conversion ratio.
Annual Capital Reinvestment Ratio for Kyung Nam Pharm Co Ltd (2007–2024)
Year-by-year Capital Reinvestment Ratio for Kyung Nam Pharm Co Ltd from 2007 to 2024. See Kyung Nam Pharm Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.91x | ₩1.84 Billion | ₩1.67 Billion | ▼ -85.0% |
| 2023 | 6.02x | ₩693.30 Million | ₩4.18 Billion | ▼ -85.2% |
| 2022 | 40.77x | ₩71.58 Million | ₩2.92 Billion | ▲ +133.9% |
| 2020 | 17.43x | ₩2.62 Billion | ₩45.58 Billion | ▲ +2749.8% |
| 2017 | 0.61x | ₩1.72 Billion | ₩1.05 Billion | ▲ +169.5% |
| 2016 | 0.23x | ₩4.89 Billion | ₩1.11 Billion | ▼ -99.0% |
| 2010 | 22.56x | ₩482.65 Million | ₩10.89 Billion | ▼ -15.9% |
| 2007 | 26.83x | ₩148.79 Million | ₩3.99 Billion | — |